BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20394413)

  • 1. Cleavage site specificity and conformational selection in type I collagen degradation.
    Salsas-Escat R; Nerenberg PS; Stultz CM
    Biochemistry; 2010 May; 49(19):4147-58. PubMed ID: 20394413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational selection and collagenolysis in type III collagen.
    Salsas-Escat R; Stultz CM
    Proteins; 2010 Feb; 78(2):325-35. PubMed ID: 19731369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural properties of a collagenous heterotrimer that mimics the collagenase cleavage site of collagen type I.
    Fiori S; Saccà B; Moroder L
    J Mol Biol; 2002 Jun; 319(5):1235-42. PubMed ID: 12079360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis.
    Nerenberg PS; Stultz CM
    J Mol Biol; 2008 Sep; 382(1):246-56. PubMed ID: 18644377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
    O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
    Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do collagenases unwind triple-helical collagen before peptide bond hydrolysis? Reinterpreting experimental observations with mathematical models.
    Nerenberg PS; Salsas-Escat R; Stultz CM
    Proteins; 2008 Mar; 70(4):1154-61. PubMed ID: 17932911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme.
    Smith GN; Mickler EA; Hasty KA; Brandt KD
    Arthritis Rheum; 1999 Jun; 42(6):1140-6. PubMed ID: 10366106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains.
    Gioia M; Monaco S; Fasciglione GF; Coletti A; Modesti A; Marini S; Coletta M
    J Mol Biol; 2007 May; 368(4):1101-13. PubMed ID: 17379243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides.
    Xu X; Wang Y; Lauer-Fields JL; Fields GB; Steffensen B
    Matrix Biol; 2004 Jun; 23(3):171-81. PubMed ID: 15296945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized unfolding of collagen explains collagenase cleavage near imino-poor sites.
    Stultz CM
    J Mol Biol; 2002 Jun; 319(5):997-1003. PubMed ID: 12079342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the degradation of type-I collagen fibrils by MMP-8.
    Lu KG; Stultz CM
    J Mol Biol; 2013 May; 425(10):1815-25. PubMed ID: 23399546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR and CD spectroscopy show that imino acid restriction of the unfolded state leads to efficient folding.
    Xu Y; Hyde T; Wang X; Bhate M; Brodsky B; Baum J
    Biochemistry; 2003 Jul; 42(29):8696-703. PubMed ID: 12873129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity.
    Schnierer S; Kleine T; Gote T; Hillemann A; Knäuper V; Tschesche H
    Biochem Biophys Res Commun; 1993 Mar; 191(2):319-26. PubMed ID: 8460992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-12 catalytic domain recognizes and cleaves at multiple sites in human skin collagen type I and type III.
    Taddese S; Jung MC; Ihling C; Heinz A; Neubert RH; Schmelzer CE
    Biochim Biophys Acta; 2010 Apr; 1804(4):731-9. PubMed ID: 19932771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and collagen catabolism.
    Lauer-Fields JL; Juska D; Fields GB
    Biopolymers; 2002; 66(1):19-32. PubMed ID: 12228918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
    Mitchell PG; Magna HA; Reeves LM; Lopresti-Morrow LL; Yocum SA; Rosner PJ; Geoghegan KF; Hambor JE
    J Clin Invest; 1996 Feb; 97(3):761-8. PubMed ID: 8609233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I collagen N-telopeptides adopt an ordered structure when docked to their helix receptor during fibrillogenesis.
    Malone JP; George A; Veis A
    Proteins; 2004 Feb; 54(2):206-15. PubMed ID: 14696182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B.
    O'Farrell TJ; Pourmotabbed T
    Arch Biochem Biophys; 1998 Jun; 354(1):24-30. PubMed ID: 9633594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of type I collagen against collagenases (type I) and thermal degradation using iron complex.
    Fathima NN; Bose MC; Rao JR; Nair BU
    J Inorg Biochem; 2006 Nov; 100(11):1774-80. PubMed ID: 16908069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.